Meeder Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
1,428
+23
+2% +$3.45K 0.01% 666
2026
Q1
$215K Buy
+1,405
New +$215K 0.01% 637

Other funds holding NVS

Meeder Advisory Services's NVS Position: Q2 2026 in Review

Meeder Advisory Services increased its Novartis (NVS) stake by 1.6% in Q2 2026, buying an estimated $3.45K and bringing the position to 1,428 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #666.

Meeder Advisory Services first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Meeder Advisory Services held 1,428 shares of Novartis worth $224K as of Q2 2026.
  • Meeder Advisory Services bought 23 Novartis shares in Q2 2026, an estimated $3.45K.
  • Novartis made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #666 holding.
  • Meeder Advisory Services first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.